7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,728.38

+51.92

+0.07%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

NasdaqCM - Delayed Quote USD

Aclarion, Inc. (ACONW)

0.0268 0.0000 (0.00%)

At close: November 3 at 1:41:56 PM EST

Loading Chart for ACONW

Chart Range Bar

Interval:

In partnership with ChartIQ

Sonida Senior Living (SNDA) Reports Q3 Loss, Lags Revenue Estimates

Sonida Senior Living (SNDA) Reports Q3 Loss, Lags Revenue Estimates

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates

Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Receives Pinnacle Award for AI Innovation

Aclarion Receives Pinnacle Award for AI Innovation

Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue Estimates

Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue Estimates

HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates

HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Aclarion to Present at the 20th Annual LD Micro Main Event

Aclarion to Present at the 20th Annual LD Micro Main Event

Mobilize your Website

View Site in Mobile | Classic

Share by: